Parabilis Medicines Inc.
PBLS | NASDAQ
$28.32
-$0.38 (-1.32%)
At close: Oct 30, 2026, 4:00 PM ET
$29.79
+$1.47 (+5.19%)
Pre-market:
Nov 2, 2026, 9:21 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|---|
Revenue | 148K | n/a | n/a | n/a |
Cost of Revenue | n/a | 618K | 618K | n/a |
Gross Profit | 148K | -618K | -618K | n/a |
Operating Income | -98.34M | -83.97M | -76.76M | -40.24M |
Interest Income | 6.62M | 3.48M | 2.31M | 1.26M |
Pretax Income | -97.78M | -80.13M | -73.14M | -38.33M |
Net Income | -97.78M | -80.13M | -73.14M | -38.33M |
Selling & General & Admin | 21.36M | 15.48M | 12.11M | 6.34M |
Research & Development | 77.13M | 67.88M | 64.03M | 33.91M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 98.49M | 83.36M | 76.14M | 40.24M |
Interest Expense | 502K | 688K | 795K | 399K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 98.49M | 83.97M | 76.76M | 40.24M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 28.91M | 2.05M | 2.02M | 2.02M |
Shares Outstanding (Diluted) | 28.91M | 2.05M | 2.02M | 2.02M |
EPS (Basic) | -36.90 | -34.94 | -24.20 | -23.84 |
EPS (Diluted) | -36.90 | -34.94 | -24.20 | -23.84 |
EBITDA | -96.08M | -80.32M | -73.18M | -37.27M |
EBIT | -97.28M | -81.54M | -74.45M | -37.93M |
Depreciation & Amortization | 1.2M | 1.22M | 1.27M | 654K |
Add to Watchlist
Select watchlists to add or remove PBLS